CO7180196A2 - Azaheterociclos como inhibidores de bir2 y/o bir3 - Google Patents

Azaheterociclos como inhibidores de bir2 y/o bir3

Info

Publication number
CO7180196A2
CO7180196A2 CO15017272A CO15017272A CO7180196A2 CO 7180196 A2 CO7180196 A2 CO 7180196A2 CO 15017272 A CO15017272 A CO 15017272A CO 15017272 A CO15017272 A CO 15017272A CO 7180196 A2 CO7180196 A2 CO 7180196A2
Authority
CO
Colombia
Prior art keywords
azaheterocycles
bir2
bir3
inhibitors
compounds
Prior art date
Application number
CO15017272A
Other languages
English (en)
Inventor
Joan Heather Hogg
Kang Le
Yan Lou
Steven Gregory Mischke
Stacy Remiszewski
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48948413&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7180196(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO7180196A2 publication Critical patent/CO7180196A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Se dan a conocer compuestos de fórmula I: o sales farmacéuticamente aceptables de los mismos, en la que R, R, R, m, n y q se definen en la presente solicitud, y métodos de utilización de dichos compuestos en el tratamiento del cáncer. 1 2 3
CO15017272A 2012-08-15 2015-01-28 Azaheterociclos como inhibidores de bir2 y/o bir3 CO7180196A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261683253P 2012-08-15 2012-08-15

Publications (1)

Publication Number Publication Date
CO7180196A2 true CO7180196A2 (es) 2015-02-09

Family

ID=48948413

Family Applications (1)

Application Number Title Priority Date Filing Date
CO15017272A CO7180196A2 (es) 2012-08-15 2015-01-28 Azaheterociclos como inhibidores de bir2 y/o bir3

Country Status (21)

Country Link
US (1) US9422332B2 (es)
EP (1) EP2885275A1 (es)
JP (1) JP6203261B2 (es)
KR (1) KR20150042792A (es)
CN (1) CN104540806B (es)
AU (1) AU2013304214A1 (es)
BR (1) BR112015003201A2 (es)
CA (1) CA2878106A1 (es)
CL (1) CL2015000333A1 (es)
CO (1) CO7180196A2 (es)
CR (1) CR20150041A (es)
EA (1) EA201590347A1 (es)
HK (1) HK1209427A1 (es)
IL (1) IL237063A0 (es)
MA (1) MA37896A1 (es)
MX (1) MX2015001905A (es)
PE (1) PE20150674A1 (es)
PH (1) PH12015500185A1 (es)
SG (1) SG11201500581WA (es)
WO (1) WO2014026882A1 (es)
ZA (1) ZA201500342B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016079527A1 (en) 2014-11-19 2016-05-26 Tetralogic Birinapant Uk Ltd Combination therapy
WO2016097773A1 (en) 2014-12-19 2016-06-23 Children's Cancer Institute Therapeutic iap antagonists for treating proliferative disorders
WO2017162674A1 (en) * 2016-03-22 2017-09-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Novel derivatives and their use as selective inhibitors of caspase-2
EP3455221B1 (en) * 2016-05-09 2020-03-11 H. Hoffnabb-La Roche Ag Dimeric compounds
CN106265764B (zh) 2016-08-18 2018-03-16 广州威溶特医药科技有限公司 Iap抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005271831A1 (en) * 2004-07-12 2006-02-16 Idun Pharmaceuticals, Inc. Tetrapeptide analogs
CN101094833A (zh) * 2004-07-12 2007-12-26 伊邓药品公司 四肽类似物
WO2011059763A2 (en) * 2009-10-28 2011-05-19 Joyant Pharmaceuticals, Inc. Dimeric smac mimetics

Also Published As

Publication number Publication date
EP2885275A1 (en) 2015-06-24
CL2015000333A1 (es) 2015-11-06
CN104540806B (zh) 2017-05-03
KR20150042792A (ko) 2015-04-21
PE20150674A1 (es) 2015-05-06
ZA201500342B (en) 2017-09-27
US20150210739A1 (en) 2015-07-30
AU2013304214A1 (en) 2015-02-12
IL237063A0 (en) 2015-03-31
US9422332B2 (en) 2016-08-23
EA201590347A1 (ru) 2015-05-29
PH12015500185B1 (en) 2015-04-20
CR20150041A (es) 2015-03-13
SG11201500581WA (en) 2015-04-29
HK1209427A1 (en) 2016-04-01
JP2015526436A (ja) 2015-09-10
CN104540806A (zh) 2015-04-22
MX2015001905A (es) 2015-06-05
JP6203261B2 (ja) 2017-09-27
BR112015003201A2 (pt) 2017-07-04
MA37896A1 (fr) 2016-09-30
CA2878106A1 (en) 2014-02-20
PH12015500185A1 (en) 2015-04-20
WO2014026882A1 (en) 2014-02-20

Similar Documents

Publication Publication Date Title
CR20150211A (es) Compuestos diméricos
CY1120480T1 (el) Ενωσεις πυραζολοπυριμιδινης
CL2016000807A1 (es) Amino heteroarilo benzamidas como inhibidores de quinasa.
CL2015000829A1 (es) Inhibidores de histona desmetilasas
CR20140166A (es) Compuestos de (hetero)arilciclopropilamina como inhibidores de lsd1
CR20150472A (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd
ECSP12012103A (es) Inhibidores de virus flaviviridae.
CO7160104A2 (es) Inhibidores de virus de hepatitis c
NI201400108A (es) Compuestos de heterociclilo
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
CL2013003313A1 (es) Compuestos derivados de 2,4-diaminoquinazolinas, sales o solvatos farmacéuticamente aceptables; composición farmacéutica que los comprende; y uso en el tratamiento de un trastorno en el que interviene la modulación de tlr7 y/o tlr8.
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CL2013002898A1 (es) Compuestos derivados de benceno sustituido con arilo o heteroarilo; composicion farmaceutica que los comprende y uso en el tratamiento del cancer.
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
CL2014002640A1 (es) Compuestos pirrolidin, piperidin o azepan sustituidos, inhibidores de met-ap2; procedimiento para prepararlos; y medicamento que los contiene.
UY34657A (es) ?derivados macrocíclicos para el tratamiento de enfermedades?.
PE20151023A1 (es) Triazolopirazinas
CO7240410A2 (es) Inhibidores macrocíclicos de virus flaviviridae
UY34201A (es) Compuestos de azaindol y métodos para el tratamiento de vih.
AR088622A1 (es) 18-METIL-6,7-METILEN-3-OXO-17-PREGN-4-EN-21,17b-CARBOLACTONA, PREPARADOS FARMACEUTICOS QUE CONTIENEN LOS COMPUESTOS MENCIONADOS Y SU USO EN LA TERAPIA DE LA ENDOMETRIOSIS
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
AR125920A2 (es) Composiciones que comprenden vortioxetina y donepezil
CL2013003563A1 (es) Compuestos derivados de amidas del ácido gambógico y sus sales; composición farmacéutica que los comprende, útil en el tratamiento del glioblastoma.
CO7180196A2 (es) Azaheterociclos como inhibidores de bir2 y/o bir3
DOP2015000060A (es) Profármacos de aminoquinazolina inhibidora de cinasa